Application 076156
- Type
- ANDA
- Sponsor
- APOTEX INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IPRATROPIUM BROMIDE | IPRATROPIUM BROMIDE | SPRAY, METERED;NASAL | 0.021MG/SPRAY | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076156-001 | IPRATROPIUM BROMIDE | IPRATROPIUM BROMIDE | 0.021MG/SPRAY | SPRAY, METERED / NASAL | AB | 2003-04-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A076156-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076156-001 | IPRATROPIUM BROMIDE | 0.021MG/SPRAY | SPRAY, METERED / NASAL | AB | 2003-04-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076156-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ipratropium Bromide | IPRATROPIUM BROMIDE | NORTHSTAR RX LLC | 6493c00f-2306-2cb6-9624-4ea678f66576 | 2026-02-27 | Warnings, Adverse reactions | 076156 ANDA076156 16714-526 |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Apotex Corp. | ac641027-929e-694d-80cd-bf770dc51aa6 | 2025-09-18 | Warnings, Adverse reactions | 076156 ANDA076156 60505-0826 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 16714-526 | Ipratropium Bromide | Ipratropium Bromide | NORTHSTAR RX LLC | ANDA | Current |
| 60505-0826 | Ipratropium Bromide | Ipratropium Bromide | Apotex Corp. | ANDA | Current |
| 60505-0826 | Ipratropium Bromide | Ipratropium Bromide | Apotex Corp. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 22540 | ORIG | 2005-07-22 |